APA (7th ed.) Citation

Burstein, H. J., & Schrag, D. (2017). Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough? JAMA: Journal of the American Medical Association, 317(1), 30. https://doi.org/10.1001/jama.2016.18979

Chicago Style (17th ed.) Citation

Burstein, Harold J., and Deborah Schrag. "Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?" JAMA: Journal of the American Medical Association 317, no. 1 (2017): 30. https://doi.org/10.1001/jama.2016.18979.

MLA (9th ed.) Citation

Burstein, Harold J., and Deborah Schrag. "Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?" JAMA: Journal of the American Medical Association, vol. 317, no. 1, 2017, p. 30, https://doi.org/10.1001/jama.2016.18979.